Thrombocytopenia associated with chronic hepatitis C

Thrombocytopenia associated with chronic hepatitis C is a hematologic complication characterized by abnormally low circulating platelet counts, typically below 150,000 per microliter, in patients with persistent hepatitis C virus (HCV) infection

Its pathogenesis is multifactorial, stemming from impaired hepatic synthesis of thrombopoietin, splenic platelet sequestration secondary to portal hypertension, direct viral suppression of bone marrow megakaryopoiesis, and immune-mediated platelet destruction While this condition heightens bleeding risks during invasive procedures, it historically represented a major clinical barrier by precluding the initiation or dose maintenance of interferon-based antiviral regimens

Its pathogenesis is multifactorial, stemming from impaired hepatic synthesis of thrombopoietin, splenic platelet sequestration secondary to portal hypertension, direct viral suppression of bone marrow megakaryopoiesis, and immune-mediated platelet destruction

Its pathogenesis is multifactorial, stemming from impaired hepatic synthesis of thrombopoietin, splenic platelet sequestration secondary to portal hypertension, direct viral suppression of bone marrow megakaryopoiesis, and immune-mediated platelet destruction

While this condition heightens bleeding risks during invasive procedures, it historically represented a major clinical barrier by precluding the initiation or dose maintenance of interferon-based antiviral regimens